Blog: Aktuelle Einblicke in die Förderung einer agilen Zusammenarbeit

29. Oktober 2024 Strategies for externally controlled single-arm trials Weiterlesen about Strategies for externally controlled single-arm trials

27. Oktober 2024 The rising potential of liquid biopsies in oncology Weiterlesen about The rising potential of liquid biopsies in oncology

22. Oktober 2024 Key CMC strategies for the development of cell and gene therapies Weiterlesen about Key CMC strategies for the development of cell and gene therapies

21. Oktober 2024 Dialysis trials need to be patient-centric AND dialysis-centric Weiterlesen about Dialysis trials need to be patient-centric AND dialysis-centric

20. Oktober 2024 Future directions in liquid biopsy technology Weiterlesen about Future directions in liquid biopsy technology

8. Oktober 2024 Advanced therapies: The advantage of early and frequent regulatory interactions Weiterlesen about Advanced therapies: The advantage of early and frequent regulatory interactions

30. September 2024 Addressing challenges of data management for cosmetic, personal care and over-the-counter products Weiterlesen about Addressing challenges of data management for cosmetic, personal care and over-the-counter products

23. September 2024 Incorporating sustainability into our clinical research operations Weiterlesen about Incorporating sustainability into our clinical research operations

16. September 2024 Medicare drug price negotiations Weiterlesen about Medicare drug price negotiations

9. September 2024 NICE technology appraisals of oncology treatments Weiterlesen about NICE technology appraisals of oncology treatments

20. August 2024 How Fortrea helped enroll over 5.000 patients 30 days early Weiterlesen about How Fortrea helped enroll over 5.000 patients 30 days early

12. August 2024 Creating a combined advanced therapy medicinal product as an SME in the EU Weiterlesen about Creating a combined advanced therapy medicinal product as an SME in the EU

7. August 2024 Dr. Gillespie goes to Capitol Hill to advocate for rare kidney disease Weiterlesen about Dr. Gillespie goes to Capitol Hill to advocate for rare kidney disease

31. Juli 2024 Understanding the three types of Advanced Therapy Medicinal Products (ATMPs) Weiterlesen about Understanding the three types of Advanced Therapy Medicinal Products (ATMPs)

11. Juli 2024 The journey of Advanced Therapy Medicinal Product (ATMP) studies in the European Union Weiterlesen about The journey of Advanced Therapy Medicinal Product (ATMP) studies in the European Union

3. Juli 2024 Clinical Development in the Precision Medicine Era Weiterlesen about Clinical Development in the Precision Medicine Era

28 June 2024 Diversity Action Plans: What sponsors need to know about the latest FDA guidance Weiterlesen about Diversity Action Plans: What sponsors need to know about the latest FDA guidance

24 June 2024 Enhancing endpoint protection in pain management clinical trials Weiterlesen about Enhancing endpoint protection in pain management clinical trials

21 June 2024 Importance of patient perspectives in neurology clinical trials Weiterlesen about Importance of patient perspectives in neurology clinical trials

11 June 2024 It's never too early for a thorough oncology product development strategy in the APAC region Weiterlesen about It's never too early for a thorough oncology product development strategy in the APAC region

4 June 2024 Highlights from Asembia 2024 Summit: Key Takeaways for the Future of a Patients Journey Weiterlesen about Highlights from Asembia 2024 Summit: Key Takeaways for the Future of a Patients Journey

31. Mai 2024 Oncology in the news: Connect with Fortrea at ASCO and access our recent webinars Weiterlesen about Oncology in the news: Connect with Fortrea at ASCO and access our recent webinars

31. Mai 2024 Empowering young voices in pediatric clinical trials: Fortrea’s commitment to child rights and participation Weiterlesen about Empowering young voices in pediatric clinical trials: Fortrea’s commitment to child rights and participation

20. Mai 2024 Feier des Clinical Trials Day: Ein Rückblick, um Fortschritte zu ermöglichen Weiterlesen über die Feier des Clinical Trials Day: Ein Rückblick, um Fortschritte zu ermöglichen

15. Mai 2024 Patientenzentrierte Lösungen für Studien im Bereich Zell- und Gentherapien Weiterlesen über patientenzentrierte Lösungen für Studien im Bereich Zell- und Gentherapien

6. Mai 2024 Scientific Research Amidst the Russia-Ukraine Conflict Fortrea's efforts in continuing scientific research and clinical trials amidst the challenges posed by the Russia-Ukraine conflict. Weiterlesen about Scientific Research Amidst the Russia-Ukraine Conflict

25. April 2024 Beauty and Personal Care Research Discover Fortrea's research on beauty and personal care, focusing on sustainable trends. Read our blog for insights into the future of beauty and personal care. Weiterlesen about Beauty and Personal Care Research

15. April 2024 Seltene Krankheiten: Ein Blick auf die Erforschung von Morbus Gaucher in Indien Explore Fortrea's focus on Gaucher disease research in India, addressing rare diseases with innovative treatment approaches. Weiterlesen über seltene Krankheiten: Ein Blick auf die Erforschung von Morbus Gaucher in Indien

25. März 2024 Focusing on Rare Kidney Diseases with Unique Collaborative Efforts Explore Fortrea's unique collaborative efforts in researching and addressing rare kidney diseases through advanced methodologies and patient-centric approaches. Weiterlesen about Focusing on Rare Kidney Diseases with Unique Collaborative Efforts

14. März 2024 Applying an Agile Approach to Hybrid Outsourcing in Clinical Trials Learn about Fortrea's agile strategies for hybrid outsourcing in clinical trials, enhancing flexibility and efficiency. Weiterlesen about Applying an Agile Approach to Hybrid Outsourcing in Clinical Trials

27. Februar 2024 Rare Disease Day: Celebrating Progress and Hope for the Future Join Fortrea in celebrating Rare Disease Day, highlighting progress in medical research and hope for the future. Weiterlesen about Rare Disease Day: Celebrating Progress and Hope for the Future

23. Februar 2024 Rare Disease Clinical Trials Explore Fortrea's advancements in rare disease clinical trials and orphan drug research. Read our blog for insights into our innovative research solutions. Weiterlesen about Rare Disease Clinical Trials

11. Februar 2024 Klinische Studien zu seltenen Krankheiten Discover Fortrea's efforts in conducting clinical trials for rare diseases, aiming to develop effective treatments. Weiterlesen about Clinical Trials in Rare Disease

25. Januar 2024 Continuous Glucose Monitoring Explore key considerations for using continuous glucose monitoring in diabetes management. Read Fortrea's blog for insights into CGM technology and strategies. Weiterlesen about Continuous Glucose Monitoring

21. Januar 2024 Clinical Trials Regulation and CTIS Stay informed with Fortrea's blog on clinical trials regulation and regulatory updates. Prepare for upcoming changes and ensure compliance in clinical research. Weiterlesen about Clinical Trials Regulation and CTIS

8. Januar 2024 Innovative Advances in Ophthalmology Medical Device Development Discover Fortrea's innovative advances in ophthalmology medical device development, enhancing eye disease treatments. Weiterlesen about Innovative Advances in Ophthalmology Medical Device Development

12. Dezember 2023 Bewertung der Wettbewerbssituation in Bezug auf Typ-2-Diabetes-Studien in Ländern in der Region Asien-Pazifik Fortrea addresses the challenges and strategies in conducting clinical trials for type 2 diabetes, aiming to improve treatment outcomes. Weiterlesen über: Bewertung der Wettbewerbssituation in Bezug auf Typ-2-Diabetes-Studien in Ländern in der Region Asien-Pazifik

4. Dezember 2023 Fortrea Shanghai Office Learn about Fortrea's Shanghai office and its sustainability initiatives. Explore our efforts towards promoting a greener and sustainable future. Weiterlesen about Fortrea Shanghai Office

20. November 2023 SGLT2 Inhibitors for Pediatric Patients Explore the benefits of SGLT2 inhibitors as renoprotective agents for pediatric patients. Fortrea's blog provides insights into diabetes medication and renal protection. Weiterlesen about SGLT2 Inhibitors for Pediatric Patients

16. November 2023 Promoting Access to Innovative Cardiac Medical Devices Fortrea's efforts in promoting access to innovative cardiac medical devices, aiming to improve cardiovascular health through cutting-edge technology. Weiterlesen about Promoting Access to Innovative Cardiac Medical Devices

27. Oktober 2023 Wichtige Erkenntnisse aus dem SCDM AC & Leadership Forum 2023 Discover the key insights and takeaways from the 2023 SCDM AC Leadership Forum, highlighting advancements and discussions in clinical data management. Weiterlesen über: Wichtige Erkenntnisse aus dem SCDM AC & Leadership Forum 2023

1. Oktober 2023 Standardisierung der Kosmetovigilanz Learn about Fortrea's efforts in standardizing cosmetovigilance to ensure the safety and efficacy of cosmetic products. Weiterlesen über: Standardisierung der Kosmetovigilanz

28. September 2023 Verschieben der Grenzen von Zell- und Gentherapien Discover Fortrea's advancements in cell and gene therapy. Read our blog for insights into the latest breakthroughs and innovative treatments in genetic medicine. Weiterlesen über: Verschieben der Grenzen von Zell- und Gentherapien

21. September 2023 Patient Safety in Clinical Trials Explore Fortrea's commitment to patient safety in clinical trials. Read our blog for insights and strategies to ensure patient protection and trial integrity. Weiterlesen about Patient Safety in Clinical Trials

21. September 2023 Leveraging Precision Medicine to Advance Clinical Trials in Latin America Learn how Fortrea is advancing clinical trials in Latin America through precision medicine, enhancing treatment efficacy and patient outcomes. Weiterlesen about Leveraging Precision Medicine to Advance Clinical Trials in Latin America

11. September 2023 Reparatur, Austausch oder Erweiterung: Wichtige Überlegungen zu Maßnahmen zur Rettung oder zum Wechsel klinischer Studien zur Entwicklung medizinischer Geräte Explore Fortrea's strategies for clinical trial rescue and transition, ensuring successful outcomes and continuity. Weiterlesen über: Reparatur, Austausch oder Erweiterung: Wichtige Überlegungen zu Maßnahmen zur Rettung oder zum Wechsel klinischer Studien zur Entwicklung medizinischer Geräte